Yatırım Fikirleri
Tüm Hisse Senetlerine Gözat
Piyasalar
Yatırım Fikirleri
›
Profitable Climbers
Screener'ı Düzenle
Yeni Hisse Senedi Uyarısı Alın
Profitable Climbers
Sonuçlar
23
1 yeni
🇺🇸 US Pazar
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Pharmaceuticals & Biotech
All Industries
Automobiles
Banks
Capital Goods
Commercial Services
Consumer Durables
Consumer Services
Diversified Financials
Energy
Consumer Retailing
Food, Beverage & Tobacco
Healthcare
Household
Insurance
Materials
Media
Pharmaceuticals & Biotech
Real Estate
Retail
Semiconductors
Software
Tech
Telecom
Transportation
Utilities
23 şirketler
1 yeni̇ şi̇rket son 7d
Şirket
Son Fiyat
7D Dönüş
1Y Dönüş
Piyasa Değeri
Analistlerin Hedefi
Değerleme
Büyüme
Bölünmüş Verim
TGTX
TG Therapeutics
US$55.72
10.2%
92.4%
US$7.8b
US$69.71
PE
17.9
E
21.3%
n/a
ZVRA
Zevra Therapeutics
US$11.85
-0.3%
27.4%
US$697.2m
US$25.00
PE
12.3
E
23.4%
n/a
CORT
Corcept Therapeutics
US$116.93
-3.4%
68.0%
US$13.0b
US$141.00
PE
232.9
E
43.0%
n/a
ALNY
Alnylam Pharmaceuticals
US$236.56
3.2%
-47.7%
US$32.0b
US$370.20
PE
40.9
E
24.0%
n/a
ETON
Eton Pharmaceuticals
US$62.62
1.9%
262.4%
US$1.8b
US$71.00
PE
141.1
E
44.9%
n/a
KNSA
Kiniksa Pharmaceuticals International
US$79.80
1.7%
138.2%
US$6.1b
US$98.00
PE
77.2
E
38.0%
n/a
ARQT
Arcutis Biotherapeutics
US$24.87
-1.9%
60.6%
US$3.2b
US$36.88
PE
109.6
E
43.0%
n/a
KRYS
Krystal Biotech
US$357.46
6.1%
137.1%
US$10.6b
US$385.00
PE
43.8
E
40.6%
n/a
LQDA
Liquidia
US$69.94
-1.6%
154.7%
US$6.4b
US$107.75
PE
45.2
E
29.5%
n/a
OMER
Omeros
US$18.22
-0.9%
328.7%
US$1.4b
US$33.00
PE
11.3
E
26.4%
n/a
ATNM
Actinium Pharmaceuticals
US$1.00
-10.7%
-42.5%
US$31.8m
US$3.50
PE
2.8
E
39.0%
n/a
OGN
Organon
US$13.76
0.1%
49.9%
US$3.6b
US$11.25
PE
17.3
E
37.0%
0.6%
ASND
Ascendis Pharma
US$249.36
-2.1%
n/a
US$16.4b
US$316.35
PE
18.9
E
13.0%
n/a
MRK
Merck
US$149.54
0.4%
79.7%
US$377.7b
US$148.73
PE
116.3
E
31.9%
2.3%
ABBV
AbbVie
US$258.15
-1.4%
24.2%
US$464.6b
US$276.59
PE
72.8
E
23.4%
2.7%
LGND
Ligand Pharmaceuticals
US$287.85
-1.0%
80.9%
US$5.6b
US$342.82
PE
29.1
E
19.5%
n/a
VCEL
Vericel
US$42.44
-2.6%
18.3%
US$2.2b
US$60.57
PE
89.7
E
32.4%
n/a
RGEN
Repligen
US$182.03
1.0%
49.0%
US$10.2b
US$185.70
PE
247.3
E
36.8%
n/a
ONC
BeOne Medicines
US$372.49
0.9%
25.0%
US$42.7b
US$432.16
PE
64.6
E
27.4%
n/a
TEVA
Teva Pharmaceutical Industries
US$37.62
2.2%
108.5%
US$44.2b
US$41.40
PE
62.1
E
26.8%
0%
PTGX
Protagonist Therapeutics
US$151.50
-2.2%
146.6%
US$9.7b
US$170.38
PE
118.2
E
28.1%
n/a
AMRX
Yeni
Amneal Pharmaceuticals
US$18.01
0.6%
88.6%
US$6.3b
US$21.00
PE
39.9
E
41.5%
0%
SHC
Sotera Health
US$19.48
1.4%
20.2%
US$5.6b
US$22.72
PE
34.0
E
21.1%
n/a
Page 1 of 1
Gösterge Tablosu
Portföyler
İzleme Listesi
Topluluk
Keşfedin
Screener